TallyHQ
github
Client · LDA

BIOTECHNOLOGY INNOVATION ORGANIZATION

5 filings 57 bills mentioned 1 registrants 5 quarters ~$7,210,000 reported
Client ID
107792

Bills lobbied on

Bills referenced in this client's quarterly filings, ranked by filing count.

HR 1672
Maintaining Investments in New Innovation Act
HCRMMMTRD
5
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
HCRMMMTRD
5
HR 1262
Mikaela Naylon Give Kids a Chance Act
HCRMMMTAX
5
HR 946
ORPHAN Cures Act
HCRMMMTAXTRD
4
S 527
Prescription Pricing for the People Act of 2025
CPTHCRMMM
4
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HCRMMMTAX
4
S 1096
Preserve Access to Affordable Generics and Biosimilars Act
CPTHCRMMM
4
S 1097
Interagency Patent Coordination and Improvement Act of 2025
CPTHCRMMM
4
S 864
HELP Copays Act
HCRMMM
3
HR 3160
PREVAIL Act
CPT
3
S 1095
Stop STALLING Act
CPTHCRMMM
3
S 1041
Affordable Prescriptions for Patients Act
CPTHCR
3
S 2658
Medication Affordability and Patent Integrity Act
CPTHCR
3
S 43
Skinny Labels, Big Savings Act
CPTHCRMMM
3
S 526
Pharmacy Benefit Manager Transparency Act of 2025
HCRMMM
3
S 705
Innovation in Pediatric Drugs Act of 2025
HCRMMM
3
S 2276
ETHIC Act
CPTHCRMMM
3
HR 3152
Patent Eligibility Restoration Act of 2025
CPT
3
S 1546
Patent Eligibility Restoration Act of 2025
CPT
3
S 1553
PREVAIL Act
CPT
3
HR 6485
Skinny Labels, Big Savings Act
CPTHCRMMM
2
HR 6423
HELP Copays Act
HCRMMM
2
HR 5256
340B ACCESS Act
HCR
2
HR 3701
Family Vaccine Protection Act
HCR
2
S 832
EPIC Act of 2025
HCR
2
HR 3493
Global Fairness in Drug Pricing Act
HCRMMM
2
HR 6166
Lowering Drug Costs for American Families Act
HCRMMM
2
S 2082
Nuclear REFUEL Act of 2025
HCR
2
S 946
MATE Improvement Act
HCRMMM
2
S 1302
Increasing Transparency in Generic Drug Applications Act
HCR
2
S 932
Give Kids a Chance Act of 2025
HCRMMMTAX
2
HR 3394
Fair Investment Opportunities for Professional Experts Act
SMB
1
HR 3375
Fair Prescription Drug Prices for Americans Act
HCRMMM
1
S 1587
Fair Prescription Drug Prices for Americans Act
HCRMMM
1
S 2115
Safe and Open Streets Act
TRD
1
HR 4777
INNOVATE Act
SMB
1
HR 3269
ETHIC Act
CPTHCRMMM
1
S 854
Risky Research Review Act
HCR
1
HR 3169
SBIR/STTR Reauthorization Act of 2025
SMB
1
HR 3521
Clinical Trial Modernization Act
HCR
1
HR 5100
To extend the SBIR and STTR programs, and for other purposes.
SMB
1
S 2924
Small Entity Update Act
SMB
1
HR 1326
DOE and USDA Interagency Research Act
AGR
1
HR 3339
Equal Opportunity for All Investors Act of 2025
SMB
1
HR 5391
Bipartisan Bulletproof Vest Partnership Program Expansion Act
HCRMMM
1
S 2764
STUDENT Act
HCRMMM
1
S 1862
ORPHAN Cures Act
HCRMMMTAX
1
HR 3348
Accredited Investor Definition Review Act
SMB
1
HR 3382
Small Entity Update Act
SMB
1
S 1818
Prescription Drug Price Relief Act of 2025
HCRMMM
1

Registrants

Lobbying firms that filed on behalf of this client.

BIOTECHNOLOGY INNOVATION ORGANIZATION 5

Source: Senate LDA quarterly filings (LD-2). Bill mentions extracted from free-text "specific issues" descriptions.